Jefferies Analyst Upgrades Corbus Pharmaceuticals to Buy Raises Price Target
On March 6, 2024, Jefferies analyst Maury Raycroft made a bold move by upgrading Corbus Pharmaceuticals (NASDAQ: CRBP) from a ...
Tag: CRBP
Corbus Pharmaceuticals Raises Funds for Clinical Development and Faces Market Fluctuations
On February 1, 2024, Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) successfully completed an underwritten public offering, raising approximately $82.2 million ...
Corbus Pharmaceuticals Holdings Unprecedented Surge and Trading Halt
On January 27, 2024, Corbus Pharmaceuticals Holdings witnessed an extraordinary surge in its stock price, causing a temporary halt in ...
Corbus Pharmaceuticals Holdings Inc Surges on Promising Drug Candidate CRB701
On January 27, 2024, Corbus Pharmaceuticals Holdings, Inc. made an exciting revelation about its drug candidate CRB-701, leading to a ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
